<?xml version="1.0" encoding="UTF-8"?>
<ref id="B56-molecules-25-03936">
 <label>56.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kang</surname>
    <given-names>C.K.</given-names>
   </name>
   <name>
    <surname>Seong</surname>
    <given-names>M.-W.</given-names>
   </name>
   <name>
    <surname>Choi</surname>
    <given-names>S.-J.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>T.S.</given-names>
   </name>
   <name>
    <surname>Choe</surname>
    <given-names>P.G.</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>S.H.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>N.-J.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>W.B.</given-names>
   </name>
   <name>
    <surname>Oh</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses</article-title>
  <source>Korean J. Intern. Med.</source>
  <year>2020</year>
  <volume>35</volume>
  <fpage>728</fpage>
  <lpage>787</lpage>
  <pub-id pub-id-type="doi">10.3904/kjim.2020.157</pub-id>
 </element-citation>
</ref>
